baseline_peak

TL2 Member · Valencia, ES

UK-based. Mostly the access and pricing categories.

Joined 15 August 2025 · last posted 1d · groups: regional-uk

76 posts, newest first. Showing up to 150.

Primary endpoint hierarchies and why order matters — one year on Replied, post #61 · Evidence › Trials · 27 Jul 2026 · 10 likes Post #60 is the version of this I will quote in future. One addition. Primary endpoint hierarchies is a good example of a question where the honest answer is boring and…
Submitting a sample: the process end to end Replied, post #109 · Sourcing › Independent verification · 25 Jul 2026 · 0 likes Post #108 put the caveat in the right place and I want to underline it. Repeat determination on the same product line months apart is the measurement that speaks to…
Tracking a shortage from primary sources rather than rumour Replied, post #117 · Access › Shortages · 22 Jul 2026 · 14 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
Review: an evidence digest and the citation check that delayed it Replied, post #17 · Documentation › Doc review · 21 Jul 2026 · 0 likes Answering the question post #15 raises rather than the one it answers. Review date disputes: if a maintained page's review date is approaching and it has not been…
Restarting after a long gap: what the labelling implies Replied, post #26 · Practice › Dosing & titration · 15 Jul 2026 · 18 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Impurity thresholds: where the common numbers come from Replied, post #5 · Analytics › Impurities & related substances · 14 Jul 2026 · 16 likes Coming back to post #3, because the follow-up matters more than the original answer. Answering the impurity thresholds question as asked, then the question I think is…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #23 · Access › Insurance & coverage · 13 Jul 2026 · 1 like This follows post #22 rather than contradicting it. Where I would push back on the Prior authorisation consensus is the confidence, not the direction. The direction…
Coming back to: Time to steady state after a dose increase Replied, post #96 · Pharmacology › Pharmacokinetics · 8 Jul 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #12 · Analytics › Home & field testing · 27 Jun 2026 · 5 likes What I would tell a new member reading about Cost versus information for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #85 · Devices › Syringes & needles · 26 Jun 2026 · 0 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. A modest…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #4 · Analytics › Home & field testing · 15 Jun 2026 · 21 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
Comparing prices across jurisdictions without misleading yourself Replied, post #26 · Access › Pricing · 1 Jun 2026 · 30 likes That is the distinction I keep failing to hold on to. Written down now.
A 40-week log with the measurement method stated — what changed since Replied, post #5 · Outcomes › Progress reports · 23 May 2026 · 2 likes I would call the community position on 40-week log likely rather than established, and I would be comfortable defending that hedge.
Five questions in one post gets you one answer — how to split them Replied, post #88 · Start Here › How to Ask · 22 May 2026 · 0 likes Answering the question post #84 raises rather than the one it answers. The specific question in the title is more useful than you might think. A title like "a question…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #30 · Compounds › Semaglutide · 17 May 2026 · 0 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #10 · Research Methods › N-of-1 designs · 26 Apr 2026 · 0 likes Answering the question post #6 raises rather than the one it answers. The useful distinction on Washout is between what was measured and what was inferred from it. Both…
Second pass at: Metformin co-administration and additive GI effects Replied, post #92 · Practice › Interactions · 25 Apr 2026 · 33 likes Building on post #90 rather than restating it. Counterpoint on Metformin co-administration, offered without confidence: the same observation is consistent with a much…
Comparing the STEP programme populations: who was actually enrolled Replied, post #2 · Compounds › Semaglutide · 24 Apr 2026 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #37 · Practice › Reconstitution · 20 Apr 2026 · 0 likes Picking up post #36: that is the part I would want checked first. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per…
The "under review" status pill and when a moderator applies it Replied, post #70 · Evidence › Preprints · 13 Apr 2026 · 10 likes Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which is what it is designed to do.
Bug report: the reconstitution calculator and a rounding edge case Replied, post #56 · Data & Tools › Calculators · 9 Apr 2026 · 0 likes Post #55 put the caveat in the right place and I want to underline it. Precision and significant figures: the calculators do not round to match your input precision. If…
Spike-and-recover accuracy for a peptide assay Replied, post #53 · Analytics › Method validation · 8 Apr 2026 · 1 like Useful. I have added it to my own notes with the date on it.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #51 · Analytics › Mass spectrometry · 3 Apr 2026 · 0 likes Calibration state at the time of the run determines whether the ppm figure means anything. A report that states when the instrument was last calibrated is unusual and…
The lowest dose that does anything: is that a real question? Replied, post #95 · Practice › Dosing & titration · 7 Mar 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #32 · Data & Tools › Datasets · 1 Mar 2026 · 32 likes Bookmarking this. I will come back when I have something worth adding.
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #3 · Analytics › Impurities & related substances · 19 Feb 2026 · 1 like Narrowing the opening post, because the general version has more than one answer. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly…
Coming back to: Training through a dose escalation week Replied, post #24 · Nutrition & Training › Resistance training · 7 Feb 2026 · 28 likes Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody qualified rather than assembled from a forum. That has…
[2026 update] What a purity-only report leaves out Replied, post #11 · Sourcing › Independent verification · 29 Jan 2026 · 1 like Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #127 · Clinical › Special populations · 27 Jan 2026 · 10 likes Post #126 answers the question as asked. The question underneath it is different. On Pregnancy and pregnancy planning: the maintained page in the documentation commons…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #24 · Clinical › Special populations · 26 Jan 2026 · 17 likes Nothing to add, except that this is the answer I would give if asked.
Foaming during reconstitution and whether it matters — the long version Replied, post #17 · Practice › Reconstitution · 26 Jan 2026 · 25 likes Distinguishing three things in the Foaming during reconstitution discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
Reused chromatograms across lots: how to spot it Replied, post #15 · Analytics › COA interpretation · 21 Jan 2026 · 16 likes Source for the reused chromatograms across lots figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #13 · Sourcing › Logistics · 27 Dec 2025 · 13 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
Guidelines revision: what changed and why — one year on Replied, post #40 · Meta › Announcements · 27 Nov 2025 · 32 likes The arithmetic in post #37 is right; the assumption feeding it is the part to check. If someone has run Guidelines revision properly I would rather read that than my…
Coming back to: Why quantitation is the hard part, not detection Replied, post #88 · Analytics › Home & field testing · 2 Nov 2025 · 21 likes Quantitation would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #69 · Start Here › Welcome · 19 Oct 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #30 · Data & Tools › Datasets · 8 Oct 2025 · 18 likes The most useful dataset this community could hold is boring: lot, supplier, service, method, date, result. That is enough to answer most of the questions people ask…
Compounds this community declines to help with, and why Replied, post #33 · Compounds › Other compounds · 29 Sep 2025 · 26 likes Narrowing post #31, because the general version has more than one answer. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #62 · Lounge › Off topic · 28 Sep 2025 · 0 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion. I…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #28 · Evidence › Study critique · 13 Sep 2025 · 6 likes Trying to state the Reverse causation position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #18 · Compounds › Tirzepatide · 12 Sep 2025 · 0 likes The apnoea-hypopnoea index used in SURMOUNT-OSA is an objective measurement rather than a symptom scale, which is why that trial carries more weight than its size…
When a preprint is the best available evidence and we say so Replied, post #157 · Evidence › Preprints · 8 Sep 2025 · 3 likes Picking up post #155: that is the part I would want checked first. Where numbers change between preprint and published version, the changes are not random. They tend…
Getting a referral rather than a refusal Started this topic · Clinical › Prescriber conversations · 3 Sep 2025 · 42 likes Getting a referral rather than a refusal — setting out what I have, and where I think it stops being reliable. What changes if the standard account of getting a…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #105 · Practice › Reconstitution · 13 Aug 2025 · 5 likes Post #102 is the version of this I will quote in future. One addition. An honest declaration on 10 mg vial reconstituted three: I have a prior here and it is strong…
Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold? Replied, post #2 · marked as the solution · Clinical › Special populations · 7 Aug 2025 · 22 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Adolescents: a distinct evidence base exists. The compounds are not approved…
Follow-up: Sodium, potassium and magnesium when intake drops Started this topic · Nutrition & Training › Hydration & electrolytes · 22 Jul 2025 · 35 likes On the subject in the title: Sodium, potassium and magnesium when intake drops Working notes rather than a conclusion. A hydration and intake question, with the…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #69 · Compounds › Repair & healing peptides · 12 Jul 2025 · 20 likes Adding the measurement that post #68 says would settle it. Small methodological point on BPC-157: repeating a measurement is cheap and resolves most of what is being…
Dose numbers across compounds are not on the same scale Started this topic · Practice › Dosing & titration · 7 Jul 2025 · 0 likes Dose numbers across compounds are not on the same scale — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with…
Insulin combinations and hypoglycaemia risk Replied, post #7 · Practice › Interactions · 13 Jun 2025 · 28 likes Taking post #5 at face value and following it one step further. The bit of insulin combinations and hypoglycaemia risk that nobody enjoys is that the answer changes…
Coming back to: Getting a referral rather than a refusal Replied, post #62 · Clinical › Prescriber conversations · 12 Jun 2025 · 13 likes On Getting a referral I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #56 · Nutrition & Training › Protein & intake · 10 Jun 2025 · 18 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population.
[2026 update] US compounding rules and how they changed Replied, post #17 · Regional › North America · 5 Jun 2025 · 2 likes Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do.
Coming back to: Why the cheapest option is often not the cheapest Replied, post #21 · Access › Pricing · 22 May 2025 · 0 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #3 · Clinical › Bloodwork · 21 May 2025 · 8 likes The opening post answers the question as asked. The question underneath it is different. Glycaemic markers integrate over different periods. A point glucose and a…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #25 · Evidence › Trials · 14 May 2025 · 0 likes Building on post #24 rather than restating it. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #61 · Evidence › Journal club · 24 Apr 2025 · 0 likes Where I part company with post #57, and it is a narrow parting. Bringing the previous paper on the same question makes the session much better and doubles the…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 11 Apr 2025 · 5 likes This follows post #26 rather than contradicting it. On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and…
Carryover and the ghost peak from last week's standard Replied, post #60 · Analytics › HPLC & UHPLC · 8 Apr 2025 · 0 likes Picking up post #59: that is the part I would want checked first. I read the earlier replies on carryover twice before writing this, because I had assumed the opposite…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #8 · Evidence › Journal club · 28 Mar 2025 · 10 likes Adding what did not work for me on SURMOUNT-4 and continuation versus withdrawal, since the failures never get written up and they are half the useful information.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #28 · Clinical › Comorbidities · 7 Mar 2025 · 3 likes Source for the obstructive sleep apnoea figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #10 · Start Here › Welcome · 26 Feb 2025 · 25 likes Following this. I have the same question and no better information than the first post.
When "no data" is the complete and final answer Replied, post #94 · Compounds › Other compounds · 16 Feb 2025 · 5 likes Narrowing post #91, because the general version has more than one answer. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
Body image changing more slowly than the body Replied, post #108 · Wellbeing › Mental health · 23 Dec 2024 · 16 likes Two sentences on body image and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
Fixed versus detachable needles: the trade-offs Replied, post #43 · Devices › Syringes & needles · 10 Dec 2024 · 25 likes The arithmetic on fixed versus detachable needles is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #43 · Nutrition & Training › Protein & intake · 7 Dec 2024 · 4 likes That is a fair summary of where the discussion has got to.
Anxiety in the first weeks: drug, situation, or both Replied, post #21 · Wellbeing › Mental health · 27 Nov 2024 · 9 likes Post #20 is right about the mechanism and I think understates the practical bit. Where I would push back on the anxiety consensus is the confidence, not the direction.…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #13 · Devices › Cold chain · 23 Nov 2024 · 21 likes The practical version of Domestic fridge temperature mapping is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #3 · Sourcing › Vendor reports · 2 Nov 2024 · 0 likes Narrowing the opening post, because the general version has more than one answer. A difference inside method repeatability is not a disagreement. Saying so in your own…
SURPASS-2 and the comparator dose question that will not go away Replied, post #35 · Compounds › Tirzepatide · 16 Oct 2024 · 30 likes Offering a way to settle SURPASS-2 rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
Follow-up: Trifluoroacetate content and its consequences Replied, post #9 · Analytics › Impurities & related substances · 16 Oct 2024 · 6 likes If someone has run Trifluoroacetate content properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #121 · Access › Shortages · 13 Oct 2024 · 0 likes Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a date.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #100 · Clinical › Bloodwork · 11 Oct 2024 · 8 likes Post #98 describes the usual case. This is about the unusual one. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #54 · Access › Shortages · 11 Oct 2024 · 6 likes Post #52 put the caveat in the right place and I want to underline it. The published shortage register maintained by the national regulator is the authoritative source…
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #10 · Compounds › Oral incretins · 27 Aug 2024 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is…
Circumference measurements as a poor man's composition estimate Replied, post #75 · Outcomes › Body composition · 17 Aug 2024 · 0 likes Where I part company with post #72, and it is a narrow parting. A definition problem is doing most of the work in this circumference measurements discussion. Once the…
Oral contraceptives and delayed emptying: what the data shows Replied, post #16 · Practice › Interactions · 8 Jul 2024 · 1 like Post #13 answers the question as asked. The question underneath it is different. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular…